Published in J Alzheimers Dis on January 01, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Mol Med (2011) 0.90
Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease. Prion (2012) 0.80
Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population. Avicenna J Med Biotechnol (2010) 0.78
Generation of Calhm1 knockout mouse and characterization of calhm1 gene expression. Protein Cell (2012) 0.78
Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis. Neurol Sci (2015) 0.75
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology (2010) 3.86
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies. World J Surg (2013) 2.21
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. Ann Intern Med (2014) 2.04
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry (2013) 1.58
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. J Alzheimers Dis (2011) 1.45
Fragile X premutation with atypical symptoms at onset. Arch Neurol (2006) 1.43
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol Aging (2006) 1.42
Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies. Am Heart J (2012) 1.33
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord (2006) 1.25
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol (2007) 1.22
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci (2009) 1.14
Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc (2002) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium (2006) 1.12
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol (2008) 1.10
A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer (2009) 1.07
Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One (2010) 1.06
Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev (2015) 1.05
Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr (2013) 1.04
Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry (2005) 1.02
KIBRA gene variants are associated with episodic memory performance in subjective memory complaints. Neurosci Lett (2008) 1.01
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Human longevity and 11p15.5: a study in 1321 centenarians. Eur J Hum Genet (2009) 1.00
Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med (2002) 0.99
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler (2009) 0.99
Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol (2006) 0.99
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.98
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. CNS Drugs (2010) 0.97
Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol (2013) 0.97
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS One (2010) 0.97
Family history of cancer and stomach cancer risk. Int J Cancer (2008) 0.96
Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev (2005) 0.96
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging (2009) 0.96
The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol (2015) 0.95
Implication of sex and SORL1 variants in italian patients with Alzheimer disease. Arch Neurol (2009) 0.95
SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population. J Alzheimers Dis (2008) 0.94
Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study. Psychiatry Res (2004) 0.94
Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. J Nucl Med (2004) 0.93
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett (2007) 0.93
Genetics of familial and sporadic Alzheimer's disease. Front Biosci (Elite Ed) (2013) 0.93
Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT. J Nucl Med (2005) 0.92
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease. Alzheimer Dis Assoc Disord (2005) 0.91
How can elderly apolipoprotein E ε4 carriers remain free from dementia? Neurobiol Aging (2012) 0.91
Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett (2004) 0.91
Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann Neurol (2004) 0.91